Browse by Audience
Skip to content
Papers of the Week
Pilocarpine 1.25% and the changing landscape of presbyopia treatment.
Authors
Abstract
Despite affecting approximately 1.8 billion individuals worldwide, until recently, a pharmacologic treatment for presbyopia was not available. This special commentary reviews the treatment of presbyopia with a focus on the recently approved medication Vuity (pilocarpine 1.25%, Allergan, an AbbVie Company).